Solid Biosciences (SLDB) announced grants of 34,550 restricted stock units to two newly hired employees. The RSUs vest in four equal installments on each one-year anniversary of the grant date until the fourth anniversary of the grant date. Vesting of the equity awards is subject to the applicable employee’s continued service with the Company through each applicable vesting date. This grant was made pursuant to the Company’s 2024 Inducement Stock Incentive Plan and was made as an inducement material to the employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Solid Biosciences Reports Increased Loss Amid R&D Expansion
- Solid Biosciences: Undervalued Gem with Promising Gene Therapy Pipeline and Upcoming Catalysts
- Solid Biosciences’ SGT-003 Therapy Shows Promise in DMD Treatment, Earning Buy Rating from Analyst
- Solid Biosciences price target lowered to $17 from $18 at Wedbush
- Solid Biosciences: Promising Gene Therapy Advancements and Strategic Initiatives Drive Buy Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue